Autonomic pharmacology Flashcards Preview

Pharm Block 1 > Autonomic pharmacology > Flashcards

Flashcards in Autonomic pharmacology Deck (27):

What is the CNS nucleus or region of the Sympathetic and Parasympathetic systems?

Sympathetic => Rostral ventrolateral medulla (RVLM) Parasympathetic => Nucleus Ambiguus


What is the exit spinal cord for the Sympathetic and Parasympathetic systems?

Sympathetic => T1-L5 Parasympathetic => CN III, VII, IX, X and S2-4


Describe the pre/post-ganglionic fibers of the Sympathetic and Parasympathetic systems.

Sympathetic => short pre-ganglionic fibers; long post-ganglionic fibers Parasympathetic => long pre-ganglionic fibers; short post-ganglionic fibers


What is the ganglionic transmitter for the Sympathetic and Parasympathetic systems?

The sympathetic and parasympathetic BOTH use ACETYLCHOLINE as their ganglionic transmitter


What do Sympathetic and Parasympathetic post-ganglionic fibers release?

Sympathetic post-ganglionic fibers: - Norepinephrine --> cardiac muscle, smooth muscle, gland cells - Acetylcholine --> sweat glands - Dopamine --> renal vascular smooth muscle - Epinephrine + Norepinephrine --> adrenal medulla Parasympathetic post-ganglionic fibers: - Acetylcholine --> cardiac muscle, smooth muscle, gland cells


Which nerves make and package Ach and NE?

CHOLINERGIC nerves make and package--> Ach NORADRENERGIC nerves make and package --> NE


Name important cholinoceptors in the PNS.


Name important adrenoceptors in the sympathetic nervous system.


Describe what happens when your BP drops

1) Drop in BP is detected by vasomotor centers => activates the sympathetic autonomic nervous system (SANS)

2) SANS => constrict arterioles => increase in SVR/TPR => Increase in BP (MAP)

3) SANS => SA node => Increase in HR => Increase in CO => Increase in BP

4) SANS => LV => Increase contractility => Increases SV => Increase CO => Increase BP

5) SANS => Veins => Increase venomotor tone => Increase venous return => Increase SV

6) SANS => kidneys => Increase NaCl retention => Increase venous treurn => Increase SV

9) SANS => adrenals => Increase NE + Epi

7) Drop in BP is detected by vasomotor centers => depress parasympathetic autonomic nervous system => depression of SA node => Increase HR

8) Drop in BP is detected by baro-receptors => pituitary => Increase ADH => increase water retention => increase SV



Norepinephrine Pharm Card

Also known as: Noradrenaline, Levophed™


Epinephrine Pharm Card

Also known as: adrenaline,EpiPen™


What is the drug class for NE?

NE pharmacologic class: direct acting adrenergic agonist

NE therapeutic class: vasopressor, vasoconstrictor


Describe NE pharmacodynamics.

NE Pharmaco dynamics:

Major action => Vasoconstriction and cardiac stimulation

1) Stimulates peripheral alpha-1 adrenoceptors 

   - Leads to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase prelaod)

   - Increases CO, SVR, and MAP

   - Decreases blood flow to skin, muscle, and kidney

2) Stimulates beta-1 receptors in the heart

   - Increases HR and contractility


Describe NE pharmacokinetics.

- F ~ 100%

- Given IV ONLY

- Metabolized by COMT and MAO (liver)

- Metabolites are excreted in urine

- T1/2 = 1-2 minutes (can be titrated quickly IV)

- Can cross the placenta, but NOT blood/brain barrier



Describe NE toxicity.

1) Excessive vasoconstriction in mesenteric vessels, peripheral arterioles

   - Leads to ischemia, infarction, and gangrene

* Reflex => bradycardia



Describe NE interactions.

1) Use cautiously in patients taking an MAO inhibitor (ie Phenelzine-use lower doses)

2) Risk of excessive hypertension in patints taking propranolol


What are special considerations for NE?

1) Correct volume depletion with IV fluids BEFORE giving NE infusion 

2) Select infusion site carefully => extravasation is a  major problem

3) Monitor patient and BP continuously in an ICU setting

4) Use catiously in pediatric and geriatric patients


What are the indications for NE use/dose/route?

- Used in adults with acute HYPOTENSION and SHOCK (related to low SVR) 

- Infuse 2-12 mcg/min


What should be monitored in patients taking NE?

- BP

- HR

- Infusion site

- Evidence of extravasation


What is the drug class for Epi?

Epi pharmacologic class => direct acting adrenergic agonist

Epi therapeutic class => vasopressor, cardiac stimulatnt, bronchodilator, adjunct to local anesthetics, treatmetn ofr anaphylaxis


Describe Epi pharmacodynamics.

Major action:

1) Stimulate peripheral alpha-1 adrenoceptors

   - Vasoconstriction => resistance arteriles, increase SVR

   - Venoconstriction => capacitance vessels, increase preload

2) Beta-1 receptors 

   - Tachycardia => increased contractility

 3) Beta-2 receptors

   - Bronchodilation => helpful in severe allergic reactions by stabilizing mast cells (anaphylaxis) 


Describe Epi pharmacokinetics.

1) Can be given by:

   - IV => immediate

   - Intramuscular => variable

   - Subcutaneously => 5-15 minutes

   - Inhalation => 1-5 minutes onset

   - Opthalmic => topical

2) Metabolized by COMT 

3) Renally excreted


Describe Epi toxicity.

1) Excessive vasoconstriction

   - HTN

   - Hemorrhagic stroke

   - Angina

   - Arrythimas


Describe Epi interactions.

- Risk of excessive HTN in patients taking propranolol


What are special considerations for Epi?

1) Utility with local anesthetics

2) Drug of choice in severe anaphylactic reactions



What are the indications for Epi use/dose/route?

1) For anaphylaxis:

   - 0.1-0.5 mg => Subcutaneously (SC) or Intramuscularly

2) For cardiac arrest:

   - 1-5 mg IV push

   - 1-4 mcg/min for infusion


What should be monitored in patients on Epi?

- BP

- HR


-Infusion site

-Evidence of extravasation